These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors. Merchant M; Moffat J; Schaefer G; Chan J; Wang X; Orr C; Cheng J; Hunsaker T; Shao L; Wang SJ; Wagle MC; Lin E; Haverty PM; Shahidi-Latham S; Ngu H; Solon M; Eastham-Anderson J; Koeppen H; Huang SA; Schwarz J; Belvin M; Kirouac D; Junttila MR PLoS One; 2018; 13(1):e0192059. PubMed ID: 29370292 [TBL] [Abstract][Full Text] [Related]
23. Correction: Molecular Mechanism for the Thermo-Sensitive Phenotype of CHO-MT58 Cell Line Harbouring a Mutant CTP:Phosphocholine Cytidylyltransferase. Marton L; Nagy GN; Ozohanics O; Lábas A; Krámos B; Oláh J; Vékey K; Vértessy BG PLoS One; 2016; 11(10):e0165871. PubMed ID: 27788274 [TBL] [Abstract][Full Text] [Related]
24. Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors. Choi YJ; Park GM; Rho JK; Kim SY; So GS; Kim HR; Choi CM; Lee JC PLoS One; 2019; 14(3):e0213984. PubMed ID: 30870512 [TBL] [Abstract][Full Text] [Related]
25. Correction: Optimal designs of the side sensitive synthetic chart for the coefficient of variation based on the median run length and expected median run length. Yeong WC; Lee PY; Lim SL; Ng PS; Khaw KW PLoS One; 2022; 17(7):e0271855. PubMed ID: 35849590 [TBL] [Abstract][Full Text] [Related]
26. Correction: AarF Domain Containing Kinase 3 (ADCK3) Mutant Cells Display Signs of Oxidative Stress, Defects in Mitochondrial Homeostasis and Lysosomal Accumulation. Cullen JK; Abdul Murad N; Yeo A; McKenzie M; Ward M; Chong KL; Schieber NL; Parton RG; Lim YC; Wolvetang E; Maghzal GJ; Stocker R; Lavin MF PLoS One; 2016; 11(7):e0160162. PubMed ID: 27442024 [TBL] [Abstract][Full Text] [Related]
27. Correction: Correction: Correction: Seagrass on the brink: Decline of threatened seagrass Posidonia australis continues following protection. PLOS ONE Staff PLoS One; 2023; 18(10):e0292583. PubMed ID: 37792731 [TBL] [Abstract][Full Text] [Related]
28. Correction: Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography. Pan G; Munukutla S; Kar A; Gardinier J; Thandavarayan RA; Palaniyandi SS PLoS One; 2018; 13(8):e0203581. PubMed ID: 30161229 [TBL] [Abstract][Full Text] [Related]
29. Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases. Pérez C; Pérez-Zúñiga FJ; Garrido F; Reytor E; Portillo F; Pajares MA PLoS One; 2016; 11(9):e0163761. PubMed ID: 27658062 [TBL] [Abstract][Full Text] [Related]
31. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer. PLOS ONE Staff PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883 [TBL] [Abstract][Full Text] [Related]
32. Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer. Zhang H; Luo M; Liang X; Wang D; Gu X; Duan C; Gu H; Chen G; Zhao X; Zhao Z; Liu C PLoS One; 2020; 15(4):e0232166. PubMed ID: 32298386 [TBL] [Abstract][Full Text] [Related]
33. Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells. PLOS ONE Staff PLoS One; 2016; 11(12):e0168429. PubMed ID: 27936215 [TBL] [Abstract][Full Text] [Related]
34. Correction: Hitting a Moving Target: A Model for Malaria Elimination in the Presence of Population Movement. Silal SP; Little F; Barnes KI; White LJ PLoS One; 2016; 11(7):e0159784. PubMed ID: 27415423 [TBL] [Abstract][Full Text] [Related]
35. Correction: CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool. Stemmer M; Thumberger T; Del Sol Keyer M; Wittbrodt J; Mateo JL PLoS One; 2017; 12(4):e0176619. PubMed ID: 28426791 [TBL] [Abstract][Full Text] [Related]
36. Correction: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. PLOS ONE Staff PLoS One; 2019; 14(2):e0212697. PubMed ID: 30768650 [TBL] [Abstract][Full Text] [Related]